News
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
3+ hour, 24+ min ago (187+ words) Study results represent a critical milestone for the investigational OTTAVA" Robotic Surgical System Abstract presented at the 2026 American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting Presidential Grand Round Sessions in San Antonio, Texas Designed for Optimized OR Workflows…...
Made Scientific and Rooster Bio Announce Strategic Technology and Supply Partnership to Expand Scalable MSC and Extracellular Vesicle Manufacturing
3+ hour, 24+ min ago (692+ words) Bio Space Made Scientific and Rooster Bio Announce Strategic Technology and Supply Partnership to Expand Scalable MSC and Extracellular Vesicle Manufacturing Partnership integrates Rooster Bio's mesenchymal stem cell and extracellular vesicle platforms into Made Scientific's end-to-end CDMO capabilities to accelerate…...
Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery
2+ hour, 51+ min ago (496+ words) Bio Space Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery Partnership combines world-class protein engineering with scalable drug development to accelerate innovation BOSTON--(BUSINESS WIRE)--Alloy Therapeutics, a leading biotechnology ecosystem company, today…...
IPF draws investor heat as biotechs target fibrosis halt, better tolerability
6+ hour, 40+ min ago (567+ words) Lung diseases are having a moment in drug development and life science investment, with idiopathic pulmonary fibrosis (IPF) gaining particular traction. IPF is'a chronic, progressive lung disease characterized by irreversible scarring (fibrosis) of lung tissue, making it stiff and difficult…...
Kerecis Drives the Fish-Skin Conversation at Leading European Wound Conference - EWMA-DEWU 2026
14+ hour, 43+ min ago (412+ words) Symposia leadership and multiple accepted abstracts position intact fish skin at the forefront of evidence-based wound management. BREMEN, Germany--(BUSINESS WIRE)--#kerecis--Kerecis, the company pioneering the use of sustainably sourced intact fish skin in cellular therapy and tissue regeneration,…...
Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist
12+ hour, 31+ min ago (327+ words) Bio Space Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist Nanomedicine expert joins Massachusetts Biomedical Initiatives (MBI) lab in Worcester to advance RNA therapeutics for musculoskeletal disease WORCESTER, Mass. , May 04, 2026 (GLOBE NEWSWIRE) -- Eascra Biotech, a nanomedicine startup,…...
Foundation Medicine to Launch Foundation One'PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics
1+ day, 2+ hour ago (424+ words) Bio Space Foundation Medicine to Launch Foundation One'PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics New solution helps guide cancer therapy selection and dosing strategies to support safer, more effective patient care Foundation One PGx includes genes associated…...
GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting
22+ hour, 37+ min ago (342+ words) Poster presentations at CIS will include two studies conducted by GC Biopharma and one externally led study from Epi Vax supported through GC Biopharma's Investigator-Initiated Research Program: Title: Foundational Analysis of the Impact of Mechanical Stress on Molecular Size Distribution…...
Armatus Introduces Scalable Potency Assay Platform for Next-Generation Gene Silencing Therapies
23+ hour, 5+ min ago (352+ words) Bio Space Armatus Introduces Scalable Potency Assay Platform for Next-Generation Gene Silencing Therapies COLUMBUS, Ohio--(BUSINESS WIRE)--Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced a new publication in Molecular Therapy Advances…...
Quiver Bioscience Receives NIH HEAL Initiative Award to Advance Nav1. 7 Antisense Therapy for Chronic Pain Through Early Clinical Trials
23+ hour, 18+ min ago (737+ words) Bio Space Quiver Bioscience Receives NIH HEAL Initiative Award to Advance Nav1. 7 Antisense Therapy for Chronic Pain Through Early Clinical Trials Multi-year grant supports advancement of QV-2421 through IND-enabling studies and first-in-human trials, powered by the Quiver Discovery Platform CAMBRIDGE, Mass....